Recruiting NA INTERVENTIONAL 1-arm
NCT05629130
Embolization in Hereditary Coagulopathies (EHCO)
Sponsor: Merit Medical Systems, Inc.
Interventions
embolization with spherical microparticles embosphere
Updated 3 times since 2022 Last updated: Nov 16, 2022 Started: Jan 16, 2023 Primary completion: Dec 31, 2028 Completion: Dec 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT05629130, this NA trial focuses on Arthropathy and Clotting Factor Deficiency and remains actively recruiting participants. Sponsored by Merit Medical Systems, Inc., it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2022 — Jul 2024 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Merit Medical Systems, Inc.
- University of Sao Paulo General Hospital
Data source: University of Sao Paulo General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .